DWA
Dorsey Wright & Associates Portfolio holdings
AUM
$421M
1-Year Return
52.54%
This Quarter Return
+16.38%
1 Year Return
+52.54%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$414M
AUM Growth
+$79.2M
(+24%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
11.25%
Top 10 Holdings %
Top 10 Hldgs %
17.26%
Holding
356
New
91
Increased
48
Reduced
145
Closed
70
Top Buys
| 1 |
Zebra Technologies
ZBRA
|
$6.93M |
| 2 |
TransDigm Group
TDG
|
$6.15M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$5.77M |
| 4 |
Keysight
KEYS
|
$4.67M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
$4.64M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$8.84M |
| 2 |
Boeing
BA
|
$7.72M |
| 3 |
Ecopetrol
EC
|
$4.96M |
| 4 |
Haemonetics
HAE
|
$4.3M |
| 5 |
RPM International
RPM
|
$3.92M |
Sector Composition
| 1 | Technology | 17.43% |
| 2 | Healthcare | 14.46% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Industrials | 6.76% |
| 5 | Materials | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
151
DELISTED
NanoString Technologies, Inc.
NSTG
| $14K | ﹤0.01% |
567
-564
| -50% | -$13.9K |
|
152
AudioCodes
AUDC
$275M
| $13K | ﹤0.01% |
926
-924
| -50% | -$13K |
|
153
Standard BioTools
LAB
$493M
| $13K | ﹤0.01% |
968
-966
| -50% | -$13K |
|
|
MSB
154
Mesabi Trust
MSB
$412M
| $13K | ﹤0.01% |
447
-447
| -50% | -$13K |
|
155
Turning Point Brands
TPB
$1.78B
| $13K | ﹤0.01% |
279
-279
| -50% | -$13K |
|
156
KalVista Pharmaceuticals
KALV
$765M
| $12K | ﹤0.01% |
433
-429
| -50% | -$11.9K |
|
157
OFG Bancorp
OFG
$2.02B
| $12K | ﹤0.01% |
621
-621
| -50% | -$12K |
|
|
RARX
158
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $12K | ﹤0.01% |
542
-537
| -50% | -$11.9K |
|
|
REGI
159
DELISTED
Renewable Energy Group, Inc.
REGI
| $12K | ﹤0.01% |
543
-543
| -50% | -$12K |
|
|
ATTU
160
DELISTED
Attunity Ltd
ATTU
| $12K | ﹤0.01% |
524
-522
| -50% | -$12K |
|
161
Avalo Therapeutics
AVTX
$134M
| $11K | ﹤0.01% |
1
| – | – |
|
162
Axsome Therapeutics
AXSM
$6.21B
| $11K | ﹤0.01% |
+793
| New | +$11K |
|
163
Krystal Biotech
KRYS
$4.33B
| $11K | ﹤0.01% |
343
-342
| -50% | -$11K |
|
164
LifeVantage
LFVN
$169M
| $11K | ﹤0.01% |
754
-750
| -50% | -$10.9K |
|
165
Mesa Laboratories
MLAB
$354M
| $11K | ﹤0.01% |
46
-45
| -49% | -$10.8K |
|
|
QTNT
166
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $11K | ﹤0.01% |
30
-30
| -50% | -$11K |
|
|
SHSP
167
DELISTED
SharpSpring, Inc.
SHSP
| $11K | ﹤0.01% |
714
-711
| -50% | -$11K |
|
|
OSIR
168
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $11K | ﹤0.01% |
597
-597
| -50% | -$11K |
|
169
Arbor Realty Trust
ABR
$2.28B
| $10K | ﹤0.01% |
800
-760
| -49% | -$9.5K |
|
170
Addus HomeCare
ADUS
$2.06B
| $10K | ﹤0.01% |
159
-159
| -50% | -$10K |
|
171
Ameresco
AMRC
$1.37B
| $10K | ﹤0.01% |
642
-642
| -50% | -$10K |
|
172
Chefs' Warehouse
CHEF
$2.66B
| $10K | ﹤0.01% |
315
-315
| -50% | -$10K |
|
173
Clarus
CLAR
$139M
| $10K | ﹤0.01% |
783
-784
| -50% | -$10K |
|
174
Ducommun
DCO
$1.36B
| $10K | ﹤0.01% |
228
-228
| -50% | -$10K |
|
175
Enphase Energy
ENPH
$4.78B
| $10K | ﹤0.01% |
+1,116
| New | +$10K |
|